Anna-Marie Hosking, MD
Dermatology · San Diego, CANPI 1962962910
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,140 of the $8,990 with a category attached, or 79.4%. Boehringer Ingelheim accounts for 92.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $8,382 and has fallen 95.7% since, to $364 in 2025.
Across 25 payments — averaging $359.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$8K
- Galderma Laboratories, L.p.$263
- AbbVie$183
- Sanofi$98
- Solta Medical, A Division Of Bausch Health US, LLC$55
- E.r. Squibb & Sons, L.L.C.$32
- plus $25 from 1 others
What the payments were for
- Consulting fees$7,14079%
- Travel & lodging$7799%
- Food & beverage$1,07112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 11 | $8,333 |
| Galderma Laboratories, L.p. | 3 | $263 |
| AbbVie | 7 | $183 |
| Sanofi | 1 | $98 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $55 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| Incyte Corporation | 1 | $25 |
How this compares
$8,990 in reported general payments places this provider in the 80th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 27 | $2,129 |
| Doxycycline Hyclate | 25 | $974 |
| Ketoconazole | 52 | $657 |
| Clobetasol Propionate | 19 | $619 |
| Fluocinonide | 11 | $333 |
| Triamcinolone Acetonide | 45 | $315 |
| Minoxidil | 19 | $242 |
| Mupirocin | 27 | $173 |
| Ciclopirox | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Diego
- Neal BhatiaSan Diego$2.5M
- Arisa OrtizSan Diego$261K
- Michael BradshawSan Diego$143K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.